AFT AFT to launch Maxigesic(R) Rapid in the United States |
04/06/24 | PRICE SENSITIVE | 112.7KB | Share |
|
AFT Distribution notice |
23/05/24 | PRICE SENSITIVE | 120.13KB | Share |
|
AFT AFT reports record revenue and earnings |
23/05/24 | PRICE SENSITIVE | 173.39KB | Share |
|
AFT AFT updates operating profit guidance to $23m to $25m |
16/02/24 | PRICE SENSITIVE | 144.72KB | Share |
|
AFT Maxigesic IV launched in the United States |
07/02/24 | PRICE SENSITIVE | 346.8KB | Share |
|
AFT AFT Pharma reports growth and global expansion |
23/11/23 | PRICE SENSITIVE | 183.91KB | Share |
|
AFT AFT welcomes US FDA approval for sale of Maxigesic IV |
18/10/23 | PRICE SENSITIVE | 119.23KB | Share |
|
AFT AFT declares maiden dividend; record revenue |
22/05/23 | PRICE SENSITIVE | 1.67MB | Share |
|
AFT Maxigesic Rapid tablets gain US FDA approval |
02/03/23 | PRICE SENSITIVE | 102.55KB | Share |
|
AFT 221124 Interim results FY23H1 App 2 amended |
24/11/22 | PRICE SENSITIVE | 184.12KB | Share |
|
AFT AFT extends growth investment as sales surge |
24/11/22 | PRICE SENSITIVE | 154.45KB | Share |
|
AFT US FDA seeks more information on Maxigesic IV(R) application |
01/07/22 | PRICE SENSITIVE | 137KB | Share |
|
AFT Annual Report revision |
23/05/22 | PRICE SENSITIVE | 7.6MB | Share |
|
AFT AFT full year results FY2022 |
23/05/22 | PRICE SENSITIVE | 187.22KB | Share |
|
AFT AFT reaffirms guidance and progresses growth plan |
18/11/21 | PRICE SENSITIVE | 225.45KB | Share |
|
AFT US FDA accepts Maxigesic IV(R) New Drug Application |
01/11/21 | PRICE SENSITIVE | 166.57KB | Share |
|
AFT MEETING: AFT: ASM Presentation and Chair's address |
06/08/21 | PRICE SENSITIVE | 160.62KB | Share |
|
AFT FLLYR: AFT: AFT delivers growth amid global disruptions |
24/05/21 | PRICE SENSITIVE | 195.92KB | Share |
|
AFT GENERAL: AFT: AFT licenses Maxigesic(R) IV in the US |
28/04/21 | PRICE SENSITIVE | 148.85KB | Share |
|
AFT GENERAL: AFT: AFT updates earnings guidance |
01/04/21 | PRICE SENSITIVE | 126.03KB | Share |
|
AFT INTERIM: AFT: FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020 |
19/11/20 | PRICE SENSITIVE | 250.06KB | Share |
|
AFT GENERAL: AFT: AFT welcomes US FDA Complete Response Letter |
09/11/20 | PRICE SENSITIVE | 120.5KB | Share |
|
AFT MKTUPDTE: AFT: AFT Pharmaceuticals Share Purchase Plan Oversubscribed |
01/07/20 | PRICE SENSITIVE | 113.76KB | Share |
|
AFT SECISSUE: AFT: Issue of ordinary shares |
15/06/20 | PRICE SENSITIVE | 121.13KB | Share |
|
AFT OFFER: AFT: AFT announces successful completion of Placement |
11/06/20 | PRICE SENSITIVE | 129.11KB | Share |
|
AFT OFFER: AFT: AFGT annoucements capital raising to support liquidity |
10/06/20 | PRICE SENSITIVE | 174.91KB | Share |
|
AFT SECISSUE: AFT: Conversion of redeemable preference shares |
20/05/20 | PRICE SENSITIVE | 113.99KB | Share |
|
AFT FLLYR: AFT: AFT FY2020 Results annoucement |
20/05/20 | PRICE SENSITIVE | 253.18KB | Share |
|
AFT AFT finalises refinancing and gives trading update |
23/03/20 | PRICE SENSITIVE | 108.33KB | Share |
|
AFT Market Trading Update |
10/03/20 | PRICE SENSITIVE | 109.04KB | Share |
|
AFT AFT on track to refinance CRG term loan facility |
27/02/20 | PRICE SENSITIVE | 106.16KB | Share |
|
AFT Condensed consolidated interim financial statements |
21/11/19 | PRICE SENSITIVE | 307.69KB | Share |
|
AFT AFT earnings rise in line with guidance |
21/11/19 | PRICE SENSITIVE | 296.58KB | Share |
|
AFT AFT to book one-off non-cash gain on Pascomer® assets |
04/11/19 | PRICE SENSITIVE | 117.44KB | Share |
|
AFT Annual Shareholders Meeting Address and Presentation |
02/08/19 | PRICE SENSITIVE | 3.03MB | Share |
|
AFT AFT Licensing Agreement for Pascomer® in North America |
05/07/19 | PRICE SENSITIVE | 158.36KB | Share |
|
AFT FY2019 Annual Report |
22/05/19 | PRICE SENSITIVE | 3.51MB | Share |
|
AFT AFT Pharmaceuticals establishes new borrowing facilities |
22/05/19 | PRICE SENSITIVE | 120.95KB | Share |
|
AFT AFT Pharmaceuticals poised for strong earnings growth |
22/05/19 | PRICE SENSITIVE | 157.27KB | Share |
|
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2018 |
22/11/18 | PRICE SENSITIVE | 224.01KB | Share |
|
AFT Maxigesic is now licensed in the Russian Federation |
28/09/18 | PRICE SENSITIVE | 50.61KB | Share |
|
AFT AFT Annual Meeting 2018 Presentation |
03/08/18 | PRICE SENSITIVE | 661.78KB | Share |
|
AFT Chairman's Address at AFT Annual Meeting |
03/08/18 | PRICE SENSITIVE | 298.42KB | Share |
|
AFT Annual Report |
19/06/18 | PRICE SENSITIVE | 3.73MB | Share |
|
AFT Annual Report FY2018 |
15/06/18 | PRICE SENSITIVE | 3.73MB | Share |
|
AFT AFT FY2018 Results Announcement |
23/05/18 | PRICE SENSITIVE | 165.65KB | Share |
|
AFT AFT Divests Non-Core Products to Focus on Key Products |
21/03/18 | PRICE SENSITIVE | 120.99KB | Share |
|
AFT FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2017 |
23/11/17 | PRICE SENSITIVE | 168.32KB | Share |
|
AFT Results for announcement to the market App1 |
23/11/17 | PRICE SENSITIVE | 107.46KB | Share |
|
AFT Interim Report FY2018 |
23/11/17 | PRICE SENSITIVE | 852.02KB | Share |
|
AFT FY2018 H1 Update Presentation |
23/11/17 | PRICE SENSITIVE | 2.3MB | Share |
|
AFT 2017 Annual Meeting Presentations |
04/08/17 | PRICE SENSITIVE | 64.39KB | Share |
|
AFT Issue of Annual Report to security holders |
12/06/17 | PRICE SENSITIVE | 1.78MB | Share |
|
AFT Share Purchase Plan Opens |
24/05/17 | PRICE SENSITIVE | 98.9KB | Share |
|
AFT AFT FY2017 Results Announcement |
24/05/17 | PRICE SENSITIVE | 203.17KB | Share |
|
AFT Maxigesic now licensed in France |
22/05/17 | PRICE SENSITIVE | 47.69KB | Share |
|
AFT AFT Pharmaceuticals Presentation - Business Update |
17/03/17 | PRICE SENSITIVE | 919.19KB | Share |
|
AFT RPS SPP Announcement |
17/03/17 | PRICE SENSITIVE | 106.03KB | Share |
|
AFT Market Update |
17/02/17 | PRICE SENSITIVE | 69.07KB | Share |
|
AFT AFT Presentation FY2017 1H Year Update - amended |
25/11/16 | PRICE SENSITIVE | 1.09MB | Share |
|
AFT AFT Half Year Announcement |
24/11/16 | PRICE SENSITIVE | 166.9KB | Share |
|
AFT AFT Half Year Announcement App I |
24/11/16 | PRICE SENSITIVE | 106.61KB | Share |
|
AFT AFT Pharmaceuticals Presentation FY2017 1H Year Update |
24/11/16 | PRICE SENSITIVE | 1.09MB | Share |
|
AFT AFT Interim Report H1 FY17 |
24/11/16 | PRICE SENSITIVE | 2.46MB | Share |
|
AFT AFT Pharmaceuticals Limited – Market Trade Update FY2017 H1 |
11/11/16 | PRICE SENSITIVE | 79.59KB | Share |